The attraction of these Treg to the tumor microenvironment may be mediated by various mechanisms, including IDO activity (Wainwright et al., 2012) and CCL2 production, which interacts with CCR4 at the surface of Treg (Chang et al., 2016). The gene discussed is CCL2; the disease is neoplasm.